HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pearson syndrome in a Diamond-Blackfan anemia cohort.

Abstract
In this issue of Blood, Gagne et al describe a cohort of 362 patients clinically classified as having Diamond-Blackfan anemia (DBA), in which 175 (48%) were found to have mutations and deletions in ribosomal protein genes or GATA1, and 8 of the remaining patients (2.2% overall) had mitochondrial gene deletions consistent with Pearson marrow-pancreas syndrome (PS). The authors propose that all patients with presumptive DBA should be tested for mitochondrial DNA (mtDNA) deletion during their initial genetic evaluation.
AuthorsBlanche P Alter
JournalBlood (Blood) Vol. 124 Issue 3 Pg. 312-3 (Jul 17 2014) ISSN: 1528-0020 [Electronic] United States
PMID25035146 (Publication Type: Journal Article, Comment)
Chemical References
  • DNA, Mitochondrial
  • Acyl-CoA Dehydrogenase, Long-Chain
Topics
  • Acyl-CoA Dehydrogenase, Long-Chain (deficiency, genetics)
  • Anemia, Diamond-Blackfan (diagnosis, genetics)
  • Congenital Bone Marrow Failure Syndromes
  • DNA, Mitochondrial (genetics)
  • Humans
  • Lipid Metabolism, Inborn Errors (diagnosis, genetics)
  • Mitochondrial Diseases (diagnosis, genetics)
  • Muscular Diseases (diagnosis, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: